Download PDF
Eur J Pediatr Surg 2023; 33(02): 158-166
DOI: 10.1055/s-0042-1749436
Original Article

Inhibiting Interleukin-6/Signal Transducers and Activators of Transduction-3/Hypoxia-Inducible Factor-1α Signaling Pathway Suppressed the Growth of Infantile Hemangioma

Aziguli Maimaiti  
1   Department of Pediatric Surgery, Children's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
,
Yeerfan Aierken  
1   Department of Pediatric Surgery, Children's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
2   Department of Pediatric Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
,
Ling Zhou
1   Department of Pediatric Surgery, Children's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
,
Jun He
1   Department of Pediatric Surgery, Children's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
,
Abudusaimi Abudureyimu
1   Department of Pediatric Surgery, Children's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
,
Shui-Xue Li 
1   Department of Pediatric Surgery, Children's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
› Author Affiliations Funding IL-6-mediated STAT3/HIF-1α/VEGFA pathway in proliferative infant hemangioma. Funding provided by the Natural Science Foundation of Xinjiang Uygur Autonomous Region, under No. 2020D01C115.
› Further Information
   Permissions and Reprints

Abstract

Objective This study aims to evaluate the expression of interleukin 6 (IL-6) in patients with infantile hemangioma (IH) and investigate the role of the IL-6/signal transducers and activators of transduction-3 (STAT3)/hypoxia-inducible factor-1α (HIF-1α) pathways in the progression of IH.

Methods Serum samples were obtained from the patients with IH and normal infants to measure IL-6 expression. Hemangioma-derived stem cells (HemSCs) were transfected with small interfering RNA (siRNA) targeting IL-6, HIF-1α, or STAT3. Then, cell viability and wound healing assays were conducted. After that, the HemSC tumor mouse model was established. The in vivo anticancer effect of the IL-6 inhibitor was investigated.

Results The patients with IH had much higher IL-6 levels compared with the healthy controls (p = 0.005). HemSCs transfected with IL-6 siRNA had significantly lower viability and migration rates than normal HemSCs. HemSCs transfected with STAT3 siRNA or HIF-1α siRNA had similar tendencies. On tumor-bearing mice, the IL-6 inhibitor treatment significantly delayed tumor growth. Compared with the control group, caspase-3 was significantly increased in the IL-6 inhibitor group (p < 0.05), whereas Ki-67 was decreased in the IL-6 inhibitor group (p < 0.05). In the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, the IL-6 inhibitor group had much higher apoptosis rates than the controls (p < 0.05).

Conclusion Our findings indicate that inhibiting the IL-6/STAT3/HIF-1α signaling pathways could suppress IH growth.

Keywords

infantile hemangioma - signal transducers and activators of transduction-3 - hypoxia inducible factor-1α - apoptosis - interleukin 6

Ethical Approval

This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of Children's Hospital of Xinjiang Uygur Autonomous Region. The Animal Care and Use Committee of Children's Hospital of Xinjiang Uygur Autonomous Region granted a project license to perform the animal experiments (grant no.: 2020101967).


Data and Materials

All data generated or analyzed during this study are included in this published article.


Authors' Contributions

A.M. and Y.A. conceived of the study, J.H. and L.Z. participated in its design, and S.-X.L. coordination and helped to draft the manuscript. All authors read and approved the final manuscript.


 ∗ These authors have contributed equally to this study and retain the first authorship.


Supplementary Material



Publication History

Received: 11 November 2021

Accepted: 17 March 2022

Article published online:
12 July 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Hashimoto A, Kunimoto K, Kawaguchi A. et al. Analysis of onset and clinical characteristics in Japanese patients with infantile hemangioma. Drug Discov Ther 2021; 15 (04) 210-213
    CrossrefPubMedGoogle Scholar
  • 2 Yamashita T, Jinnin M, Makino K. et al. Serum cytokine profiles are altered in patients with progressive infantile hemangioma. Biosci Trends 2018; 12 (04) 438-441
    CrossrefPubMedGoogle Scholar
  • 3 Wu ZB, Shi SL, Pan FJ, Li L, Chen HY. Propranolol inhibits infantile hemangioma by regulating the miR-424/vascular endothelial growth factor-A (VEGFA) axis. Transl Pediatr 2021; 10 (07) 1867-1876
    CrossrefPubMedGoogle Scholar
  • 4 Sun X, Liu X, Lu N, Yao S, Xu X, Niu L. Short-term curative effect and safety of propranolol combined with laser in the treatment of infantile hemangiomas. Oncol Lett 2018; 16 (05) 6561-6565
    PubMedGoogle Scholar
  • 5 Gai X, Zhou P, Xu M, Liu Z, Zheng X, Liu Q. Hyperactivation of IL-6/STAT3 pathway leaded to the poor prognosis of post-TACE HCCs by HIF-1α/SNAI1 axis-induced epithelial to mesenchymal transition. J Cancer 2020; 11 (03) 570-582
    CrossrefPubMedGoogle Scholar
  • 6 Liu H, Ren G, Wang T. et al. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition. Carcinogenesis 2015; 36 (04) 459-468
    CrossrefPubMedGoogle Scholar
  • 7 Gao P, Niu N, Wei T. et al. The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis. Oncotarget 2017; 8 (40) 69139-69161
    CrossrefPubMedGoogle Scholar
  • 8 Zegeye MM, Andersson B, Sirsjö A, Ljungberg LU. IL-6 trans-signaling impairs sprouting angiogenesis by inhibiting migration, proliferation and tube formation of human endothelial cells. Cells 2020; 9 (06) 1414
    CrossrefPubMedGoogle Scholar
  • 9 Hegde M, Guruprasad KP, Ramachandra L, Satyamoorthy K, Joshi MB. Interleukin-6-mediated epigenetic control of the VEGFR2 gene induces disorganized angiogenesis in human breast tumors. J Biol Chem 2020; 295 (34) 12086-12098
    CrossrefPubMedGoogle Scholar
  • 10 Lin Y, He Z, Ye J. et al. Progress in understanding the IL-6/STAT3 pathway in colorectal cancer. OncoTargets Ther 2020; 13: 13023-13032
    CrossrefPubMedGoogle Scholar
  • 11 Leng K, Xu Y, Kang P. et al. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway. Cell Death Dis 2019; 10 (04) 262
    CrossrefPubMedGoogle Scholar
  • 12 Masjedi A, Ahmadi A, Atyabi F. et al. Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. Int J Biol Macromol 2020; 149: 487-500
    CrossrefPubMedGoogle Scholar
  • 13 Fu X, Zhai S, Yuan J. Interleukin-6 (IL-6) triggers the malignancy of hemangioma cells via activation of HIF-1α/VEGFA signals. Eur J Pharmacol 2018; 841: 82-89
    CrossrefPubMedGoogle Scholar
  • 14 Li Y, Xu J, Xu C. et al. Metabolism and disposition of corylifol A from Psoralea corylifolia: metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A-O-glucuronide in HeLa1A1 cells. Xenobiotica 2020; 50 (08) 997-1008
    CrossrefPubMedGoogle Scholar
  • 15 Fan H, Li J, Wang J, Hu Z. Long non-coding RNAs (lncRNAs) tumor-suppressive role of lncRNA on chromosome 8p12 (TSLNC8) inhibits tumor metastasis and promotes apoptosis by regulating interleukin 6 (IL-6)/signal transducer and activator of transcription 3 (STAT3)/hypoxia-inducible factor 1-alpha (HIF-1α) signaling pathway in non-small cell lung cancer. Med Sci Monit 2019; 25: 7624-7633
    CrossrefPubMedGoogle Scholar
  • 16 Wang Z, Yuan Y, Zhuang H. et al. Hepatic haemangiomas: possible association with IL-17. J Clin Pathol 2012; 65 (02) 146-151
    CrossrefPubMedGoogle Scholar
  • 17 Kitamura H, Ohno Y, Toyoshima Y. et al. Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer Sci 2017; 108 (10) 1947-1952
    CrossrefPubMedGoogle Scholar
  • 18 Li H, Jia Y, Wang Y. Targeting HIF-1α signaling pathway for gastric cancer treatment. Pharmazie 2019; 74 (01) 3-7
    PubMedGoogle Scholar
  • 19 Ioannou M, Paraskeva E, Baxevanidou K. et al. HIF-1α in colorectal carcinoma: review of the literature. J BUON 2015; 20 (03) 680-689
    PubMedGoogle Scholar
  • 20 Dong Z, Wang Y. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3. Pathol Res Pract 2019; 215 (03) 571-579
    CrossrefPubMedGoogle Scholar
  • 21 Lang SA, Moser C, Gaumann A. et al. Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth. Clin Cancer Res 2007; 13 (21) 6459-6468
    CrossrefPubMedGoogle Scholar
  • 22 Zehani A, Chelly I, Haouet S, Kchir N. Prognostic value of Ki67: comparison of the proliferation index between meningiomas with and without infiltration of glial tissue. Tunis Med 2017; 95 (07) 466-470
    PubMedGoogle Scholar
  • 23 Liu LQ, Nie SP, Shen MY. et al. Tea polysaccharides inhibit colitis-associated colorectal cancer via interleukin-6/STAT3 pathway. J Agric Food Chem 2018; 66 (17) 4384-4393
    CrossrefPubMedGoogle Scholar
  • 24 Xu S, Yu C, Ma X. et al. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells. Eur J Pharmacol 2021; 894: 173817
    CrossrefPubMedGoogle Scholar
  • 25 Kim SR, Bae MK, Kim JY, Wee HJ, Yoo MA, Bae SK. Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells. Biochem Biophys Res Commun 2009; 387 (02) 342-347
    CrossrefPubMedGoogle Scholar
  • 26 Jiang Q, Li Q, Chen H. et al. Scutellaria barbata D. Don inhibits growth and induces apoptosis by suppressing IL-6-inducible STAT3 pathway activation in human colorectal cancer cells. Exp Ther Med 2015; 10 (04) 1602-1608
    CrossrefPubMedGoogle Scholar
  • 27 Jiang M, Qi L, Li L, Li Y. The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer. Cell Death Discov 2020; 6: 112
    CrossrefPubMedGoogle Scholar
  • 28 Crisafulli S, Isgrò V, La Corte L, Atzeni F, Trifirò G. Potential role of anti-interleukin (IL)-6 drugs in the treatment of COVID-19: rationale, clinical evidence and risks. BioDrugs 2020; 34 (04) 415-422
    CrossrefPubMedGoogle Scholar